Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis

DOI QR Code

Hyo-Cheol Kim (Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine)

Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011;140:497-507.E2 https://doi.org/10.1053/j.gastro.2010.10.049
Kim GH, Kim JH, Kim PH, Chu HH, Gwon DI, Ko HK. Emerging trends in the treatment of advanced hepatocellular carcinoma: a radiological perspective. Korean J Radiol 2021;22:1822-1833 https://doi.org/10.3348/kjr.2021.0229
Mulcahy MF, Mahvash A, Pracht M, Montazeri AH, Bandula S, Martin RCG 2nd, et al. Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial. J Clin Oncol 2021;10;39:3897-3907 https://doi.org/10.1200/JCO.21.01839
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol 2021;6:17-29 https://doi.org/10.1016/S2468-1253(20)30290-9